September is National Prostate Cancer Awareness Month, and Philadelphia CyberKnife encourages men seeking prostate cancer treatment to educate themselves on the range of options available to treat the disease.

1. Did you know?
September is
Prostate Cancer
Awareness
Month
A
Service
of
Delaware
County
Memorial
Hospital
2010
West
Chester
Pike
Suite
115
Havertown,
PA
19083
(610)
446-­‐6850
www.phillycyberknife.com

2. Did you know?
The
American
Cancer
Society
esFmates
241,740
new
prostate
cancer
diagnoses
in
2012.
Quick
stats:
• 1
in
6
men
will
be
diagnosed
with
prostate
cancer
during
his
life:me.
• Prostate
cancer
occurs
mainly
in
older
men.
Nearly
two-­‐thirds
of
cases
are
diagnosed
in
men
aged
65
or
above,
and
it
is
rare
before
age
40.
The
average
age
at
the
:me
of
diagnosis
is
about
67.
• More
than
2.5
million
men
in
the
United
States
who
have
been
diagnosed
with
prostate
cancer
at
some
point
are
s:ll
alive
today,
thanks
to
advancements
in
treatment.
2010
West
Chester
Pike
Suite
115
Havertown,
PA
19083
(610)
446-­‐6850
www.phillycyberknife.com

3. Did you know?
CyberKnife
can
noninvasively
treat
prostate
cancer
in
five
or
fewer
treatment
sessions.
How
it
works:
• CyberKnife
treats
prostate
cancer
with
a
procedure
called
stereotac:c
body
radia:on
therapy,
a
noninvasive
method
of
trea:ng
tumors
with
precisely
targeted
high-­‐dose
radia:on.
The
result
is
greatly
increased
accuracy
that
spares
healthy
Fssue.
• Prior
to
treatment,
small
metal
:ssue
markers
known
as
fiducials
are
implanted
in
the
prostate
to
help
the
CyberKnife
pinpoint
the
tumor
loca:on
throughout
each
treatment,
ensuring
the
radiaFon
beams
delivered
during
treatment
are
always
locked
on
the
tumor.
• Pa:ents
are
then
scheduled
for
no
more
than
five
CyberKnife
treatments.
Each
treatment
takes
about
30
-­‐
40
minutes,
and
paFents
can
return
to
their
normal
rouFnes
following
each
procedure.
• In
recent
years,
CyberKnife
has
gained
awareness
among
prostate
cancer
pa:ents
in
par:cular.
Many
men
are
drawn
to
the
convenience
of
shorter
treatment
and
fewer
side
effects.
2010
West
Chester
Pike
Suite
115
Havertown,
PA
19083
(610)
446-­‐6850
www.phillycyberknife.com

4. Our Center
Philadelphia CyberKnife established the first CyberKnife program in the greater Philadelphia area
and has one of the most experienced CyberKnife clinical teams in the region. The center is actively
engaged in research with team members publishing several scientific papers on the treatment of
prostate cancer. Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a
member of the Crozer-Keystone Health System.
Medical Director: Dr. Luther Brady
Associate Medical Director: Dr. John Lamond
DCMH Chief of Radiation Oncology: Dr. Rachelle Lanicano
Chief Medical Physicist: Jun Yang, Ph.D., DABR
CyberKnife Nurse: Michael Good
Other Resources
2010
West
Chester
Pike
Suite
115
Havertown,
PA
19083
(610)
446-­‐6850
www.phillycyberknife.com